COc1ccc([C@]23Cc4ccccc4[C@H](O2)c2c(cc(-c4ccccc4)oc2=O)O3)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?